Cargando…

SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development

Disclosure: T. Moreno: None. P. Rodrigues: None. S. Ribeiro: None. D.M. Carvalho: None. Introduction: Ovotesticular disorder of sex development (OT-DSD) is a rare condition characterized by the presence of both ovarian and testicular tissue in the gonads. Management and sex designation of these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Telma, Rodrigues, Pedro, Ribeiro, Sara, Carvalho, Davide M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555136/
http://dx.doi.org/10.1210/jendso/bvad114.2066
_version_ 1785116583253770240
author Moreno, Telma
Rodrigues, Pedro
Ribeiro, Sara
Carvalho, Davide M
author_facet Moreno, Telma
Rodrigues, Pedro
Ribeiro, Sara
Carvalho, Davide M
author_sort Moreno, Telma
collection PubMed
description Disclosure: T. Moreno: None. P. Rodrigues: None. S. Ribeiro: None. D.M. Carvalho: None. Introduction: Ovotesticular disorder of sex development (OT-DSD) is a rare condition characterized by the presence of both ovarian and testicular tissue in the gonads. Management and sex designation of these patients depend on several factors and an underlying potential for gender dysphoria should be acknowledged.Clinical Case: A 12-month-old patient from Guinea-Bissau, born from consanguineous parents, was referred to Pediatric Surgery due to atypical genitalia. Karyotype was 46,XX and SRY gene analysis was negative. Genitoscopy showed absence of a vagina and a uterus was not found on magnetic resonance imaging. An exploratory laparotomy and biopsy of the gonads was performed. The pathology report confirmed the presence of gonadal ovarian and testicular tissue, establishing the diagnosis of OT-DSD. Surgical removal of both gonads and clitoroplasty was performed and a female sex designation was attributed. Endocrinology follow-up was started at the age of 8 and the first physical examination revealed weight 48.6 kg (> P97), height 135.5 cm (P90–97); Tanner stage I (P1A1M0) and a blind vagina with normal clitoris size. Blood tests showed FSH 12.53 mUI/L, LH 1.07 mUI/L, estradiol 5.8 pg/mL and total testosterone 0.04 ng/mL. Reconstructive surgery for a neovagina was performed at 13-years-old and, two years later, the patient was started on hormone replacement therapy with transdermic estradiol. At the age of 16, the patient manifested gender dysphoria issues, decided to stop estradiol and was referred for psychiatric evaluation. Two years later, intramuscular testosterone enanthate was initiated but treatment was stopped after a six-month trial, as the patient claims to identify as male but is not interested in seeking hormone treatment at this point.Conclusion: OT-DSD is an uncommon condition, raising issues of gender assignment that are dependent on factors such as age at diagnosis, phenotype, internal structures and reproductive potential. Scarce data exists on long-term outcomes in OT-DSD, including the frequency of gender dysphoria in these patients. Gender identity is an important factor to consider on long-term follow-up of OT-DSD patients. Presentation: Saturday, June 17, 2023
format Online
Article
Text
id pubmed-10555136
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105551362023-10-06 SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development Moreno, Telma Rodrigues, Pedro Ribeiro, Sara Carvalho, Davide M J Endocr Soc Transgender Medicine Disclosure: T. Moreno: None. P. Rodrigues: None. S. Ribeiro: None. D.M. Carvalho: None. Introduction: Ovotesticular disorder of sex development (OT-DSD) is a rare condition characterized by the presence of both ovarian and testicular tissue in the gonads. Management and sex designation of these patients depend on several factors and an underlying potential for gender dysphoria should be acknowledged.Clinical Case: A 12-month-old patient from Guinea-Bissau, born from consanguineous parents, was referred to Pediatric Surgery due to atypical genitalia. Karyotype was 46,XX and SRY gene analysis was negative. Genitoscopy showed absence of a vagina and a uterus was not found on magnetic resonance imaging. An exploratory laparotomy and biopsy of the gonads was performed. The pathology report confirmed the presence of gonadal ovarian and testicular tissue, establishing the diagnosis of OT-DSD. Surgical removal of both gonads and clitoroplasty was performed and a female sex designation was attributed. Endocrinology follow-up was started at the age of 8 and the first physical examination revealed weight 48.6 kg (> P97), height 135.5 cm (P90–97); Tanner stage I (P1A1M0) and a blind vagina with normal clitoris size. Blood tests showed FSH 12.53 mUI/L, LH 1.07 mUI/L, estradiol 5.8 pg/mL and total testosterone 0.04 ng/mL. Reconstructive surgery for a neovagina was performed at 13-years-old and, two years later, the patient was started on hormone replacement therapy with transdermic estradiol. At the age of 16, the patient manifested gender dysphoria issues, decided to stop estradiol and was referred for psychiatric evaluation. Two years later, intramuscular testosterone enanthate was initiated but treatment was stopped after a six-month trial, as the patient claims to identify as male but is not interested in seeking hormone treatment at this point.Conclusion: OT-DSD is an uncommon condition, raising issues of gender assignment that are dependent on factors such as age at diagnosis, phenotype, internal structures and reproductive potential. Scarce data exists on long-term outcomes in OT-DSD, including the frequency of gender dysphoria in these patients. Gender identity is an important factor to consider on long-term follow-up of OT-DSD patients. Presentation: Saturday, June 17, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10555136/ http://dx.doi.org/10.1210/jendso/bvad114.2066 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Transgender Medicine
Moreno, Telma
Rodrigues, Pedro
Ribeiro, Sara
Carvalho, Davide M
SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title_full SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title_fullStr SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title_full_unstemmed SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title_short SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
title_sort sat395 gender dysphoria in a patient with ovotesticular disorder of sex development
topic Transgender Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555136/
http://dx.doi.org/10.1210/jendso/bvad114.2066
work_keys_str_mv AT morenotelma sat395genderdysphoriainapatientwithovotesticulardisorderofsexdevelopment
AT rodriguespedro sat395genderdysphoriainapatientwithovotesticulardisorderofsexdevelopment
AT ribeirosara sat395genderdysphoriainapatientwithovotesticulardisorderofsexdevelopment
AT carvalhodavidem sat395genderdysphoriainapatientwithovotesticulardisorderofsexdevelopment